TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,649,000 | +944.6% | 492,661 | +476.2% | 0.00% | – |
| Q2 2021 | $828,000 | -39.9% | 85,498 | -33.5% | 0.00% | – |
| Q1 2021 | $1,377,000 | -61.5% | 128,543 | -47.1% | 0.00% | -100.0% |
| Q4 2020 | $3,572,000 | -26.0% | 242,819 | -28.6% | 0.00% | -33.3% |
| Q3 2020 | $4,828,000 | +1279.4% | 340,187 | +685.7% | 0.00% | – |
| Q2 2020 | $350,000 | +104.7% | 43,300 | -0.2% | 0.00% | – |
| Q1 2020 | $171,000 | +489.7% | 43,405 | +51.8% | 0.00% | – |
| Q4 2019 | $29,000 | +107.1% | 28,588 | +27.1% | 0.00% | – |
| Q1 2019 | $14,000 | -67.4% | 22,494 | -8.8% | 0.00% | – |
| Q4 2018 | $43,000 | -60.6% | 24,662 | +28.2% | 0.00% | – |
| Q4 2016 | $109,000 | – | 19,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 206,800 | $36,314,000 | 8.27% |
| Fairmount Funds Management LLC | 886,281 | $15,563,000 | 5.66% |
| FRAZIER MANAGEMENT LLC | 3,123,107 | $54,984,000 | 4.40% |
| ACT CAPITAL MANAGEMENT, LLC | 466,000 | $8,183,000 | 4.24% |
| RAMIUS ADVISORS LLC | 338,042 | $5,936,000 | 3.54% |
| Western Standard LLC | 265,355 | $4,660,000 | 2.65% |
| HAVENS ADVISORS LLC | 109,000 | $1,914,000 | 2.30% |
| Crabel Capital Management, LLC | 423,490 | $7,436,000 | 2.29% |
| S. MUOIO & CO. LLC | 160,000 | $2,810,000 | 2.16% |
| Omni Partners US LLC | 2,366,824 | $41,561,000 | 2.13% |